Abstract
The multicenter prospective randomized control trial of single-level arthroplasty compared to anterior-posterior spinal fusion in patients with functionally-disabling discogenic back pain provided the clinical dataset for the PMA study leading to FDA-approval for ProDisc-L (TDR) in August 2006. The results of the two-year data has been previously published.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
